"A multi-centre randomized, open-label phase II trial of erlotinib plus" by M. G. Michael, Michael Johnston et al.

Skip to main content

Faculty of Science - Papers (Archive)

Title

A multi-centre randomized, open-label phase II trial of erlotinib plus gemcitabine or gemcitabine monotherapy as first-line therapy in ECOG PS2 patients with chemo-naive advanced NSCLC

Authors

M. G. Michael, University of WollongongFollow
Michael Johnston, Roche Prod Pty Ltd
Stephen Clarke
Richard De Boer, Royal Melbourne Hospital
Phillip R. Clingan, University of WollongongFollow
Nick Pavlakis, Royal N Shore Hosp

RIS ID

31631

Included in

Life Sciences Commons, Physical Sciences and Mathematics Commons, Social and Behavioral Sciences Commons

COinS